CardioTech Announces Conference Call on February 12 at 2:30 PM Eastern for Third Quarter of Fiscal 2008

WILMINGTON, Mass., Feb. 5 CardioTechInternational, Inc. (Amex: CTE), a developer and manufacturer of advancedmaterials and medical devices for the treatment of cardiovascular and otherdiseases, announced today that it will release its fiscal 2008 third quarterfinancial results before the market opens on Tuesday, February 12, 2008.Following the release, the Company will host a conference call for investorsat 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal third quarter resultsand recent developments.

Participants should dial-in (866) 802-4355 Conference ID# 1191648 or (703)639-1323 outside the U.S. Please dial-in 10 minutes before the call isscheduled to begin. A replay of the call will be available for two weeksfollowing the call at (888)-266-2081 ID# 1191648 and on the Company's website.

About CardioTech International:

CardioTech is a developer of advanced polymer materials and manufacturerof medical products for the treatment and diagnosis of a broad range ofdisease states. The Company's business model leverages its proprietarymaterials science technology and manufacturing expertise in order to expandits product sales and royalty and license fee income. It develops nextgeneration polymers and manufactures new and complex medical devices tocustomers' unique specifications. CardioTech is conducting its first clinicaltrial for regulatory approval in Europe for its CardioPass synthetic coronarybypass graft. More information about CardioTech is available at its website:http://www.cardiotech-inc.com.For Further Information Contact: Eric Walters Vice President & Chief Financial Officer CardioTech International, Inc. 978-657-0075 [email protected] Sylvia Dresner Senior Vice President VMW Corporate & Investor Relations 212-616-6161 [email protected]

SOURCE CardioTech International, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...